CVS Group plc, a leading provider of veterinary services in the UK, Australia, the Netherlands, and the Republic of Ireland, has confirmed that certain employees exercised options under the CVS Group 2020 SAYE Plan, resulting in the issuance of 11,207 ordinary shares of 0.2 pence each. These new shares were issued to satisfy the balance of ordinary shares arising from the exercise. The total issued share capital of the company now stands at 71,712,970 ordinary shares, each carrying one voting right, with no ordinary shares held in treasury.

The company has a total of 71,712,970 voting rights, which shareholders may use as the denominator for the calculations to determine if they are required to notify their interest or a change to their interest in the company under the FCA's Disclosure Guidance and Transparency Rules.

CVS Group plc operates c.500 veterinary practices across its markets, including specialist referral hospitals, out-of-hours sites, laboratories, crematoria, buying groups, and an online retail business. The company is focused on providing high-quality clinical services to its clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy.

For further information, shareholders can contact CVS Group plc or its nominated adviser and broker, Peel Hunt LLP, and joint broker, Berenberg. Additionally, the company's financial PR contact is Camarco.

This exercise of options and the resulting increase in issued share capital and voting rights reflect the ongoing activities and growth of CVS Group plc as it continues to provide veterinary services and expand its operations across multiple markets.